Trial intelligence / Profile preview

Needle-free ID Influenza Vaccine in Infants

NCT00386542Phase 2Completed

Start
Oct 2006
Primary completion
Nov 2009
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of influenza vaccine in influenza (3 arms). Primary endpoint: Rates of seroconversion (SC) on HI assay. Started Oct 2006; status: completed.

02

Drugs

influenza vaccine
03

Conditions

influenza

Beyond the preview

Go deeper on NCT00386542.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00386542.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call